Crossmark

The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer

Crossref DOI link: https://doi.org/10.1186/1757-2215-7-48

Published Online: 2014-05-07

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kobayashi, Masanori

Chiba, Asako

Izawa, Hiromi

Yanagida, Eri

Okamoto, Masato

Shimodaira, Shigetaka

Yonemitsu, Yoshikazu

Shibamoto, Yuta

Suzuki, Noboru

Nagaya, Masaki

,
More Information

Article History

Received: 25 January 2014

Accepted: 30 April 2014

First Online: 7 May 2014